Jeenduang Nutjaree, Promptmas Chamras, Pongrapeeporn Klai-Upsorn S, Porntadavity Sureerut
Department of Clinical Chemistry, Faculty of Medical Technology, Mahidol University, 2 Pran Nok Road, Bangkok 10700, Thailand.
Heart Genetics Company, Bangkok 10400, Thailand.
Biochem Biophys Res Commun. 2008 Dec 12;377(2):355-360. doi: 10.1016/j.bbrc.2008.09.151. Epub 2008 Oct 16.
The low-density lipoprotein receptor (LDLR) is a key regulator of cholesterol homeostasis, and defects in the function of LDLR result in familial hypercholesterolemia (FH). In the present study, we performed structural analyses of two novel LDLR mutations, D151Y and M391T. Both mutations occurred in conserved residues of LDLR. The D151Y mutation, in the ligand binding domain, caused an elimination of a hydrogen bond in the calcium binding site, higher solvent accessibility and a loss of negative charge in the Y151 residue. On the other hand, the M391T mutation, in the beta-propeller of the epidermal growth factor (EGF) precursor homology domain, caused an additional hydrogen bond to form, higher solvent accessibility and a distortion of the beta-strand. These data suggest that the irregular structures of the mutated LDLRs are likely to cause the functional defect that contributes to the pathology of FH.
低密度脂蛋白受体(LDLR)是胆固醇稳态的关键调节因子,LDLR功能缺陷会导致家族性高胆固醇血症(FH)。在本研究中,我们对两个新的LDLR突变D151Y和M391T进行了结构分析。这两个突变均发生在LDLR的保守残基中。位于配体结合域的D151Y突变导致钙结合位点的氢键消除、溶剂可及性增加以及Y151残基负电荷丧失。另一方面,位于表皮生长因子(EGF)前体同源域β-螺旋桨的M391T突变导致额外氢键形成、溶剂可及性增加以及β-链扭曲。这些数据表明,突变的LDLR的不规则结构可能导致功能缺陷,进而促成FH的病理过程。